XML 15 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
Emerald Medical Applications Corp. - Statements of Operations
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
$ / shares
shares
Sep. 30, 2014
USD ($)
$ / shares
shares
Sep. 30, 2015
USD ($)
$ / shares
shares
Sep. 30, 2014
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2013
USD ($)
$ / shares
shares
Statements of Operations            
Revenue $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Expenses:            
Other operating expenses (618,599) 0 (618,599) 0 0 0
Research and development expenses (252,498) 0 (499,898) 0 0 0
General and administrative expenses $ (364,730) $ 0 $ (539,121) $ 0 $ (28,125) $ (41,200)
Total expenses (1,235,827) 0 (1,657,618) 0 (28,125) (41,200)
Loss from operations $ (1,235,827) $ 0 $ (1,657,618) $ 0 $ (28,125) $ (41,200)
Interest expense (6,934) 0 (18,763) 0 (20,745) (10,200)
Stock-based compensation (5,343,088) 0 (5,343,088) 0 0 0
Change in fair value of derivative $ 20,165 $ 0 $ 20,532 $ 0 $ 0 $ 0
Gain / (loss) from foreign currency 0 0 1,808 0 0 0
Gain / (loss) on debt settlement (678,027) 0 (678,027) 0 0 0
Amortization of debt discount $ 0 $ 0 $ 0 $ 0 $ (125,000) $ 0
Financial income (expense) (6,007,884) 0 (6,017,538) 0 (145,745) (10,200)
Provision for income taxes 0 0 0 0 0 0
Basic net loss per share | $ / shares $ (0.54) $ 0.00 $ (0.81) $ 0.00 $ (0.26) $ (0.12)
Weighted average shares outstanding - basic | shares 13,413,006 7,438,141 9,451,649 7,438,141 661,111 423,782